Differential stability of control gene and fusion gene transcripts over time may hamper accurate quantification of minimal residual disease – a study within the Europe Against Cancer Program
Open Access
- 12 February 2004
- journal article
- other
- Published by Springer Nature in Leukemia
- Vol. 18 (4) , 884-886
- https://doi.org/10.1038/sj.leu.2403309
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer programLeukemia, 2003
- Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer ProgramLeukemia, 2003
- Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspectsLeukemia, 2003
- Substantial changes in gene expression level due to the storage temperature and storage duration of human whole bloodClinical and Laboratory Haematology, 2002
- Minimal residual disease in leukaemia patientsThe Lancet Oncology, 2001
- Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapseBlood, 2000
- Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t(12;21)TEL-AML1 fusion transcriptGenes, Chromosomes and Cancer, 1999